Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2014
08/14/2014WO2014121942A1 Macrocyclic pyridazinone derivatives
08/14/2014WO2014121417A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121416A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014101295A3 Isoxazole derivative that inhibits activity of janus kinases (jaks)
08/14/2014WO2014068341A4 Chiral fluorinating reagents
08/14/2014WO2009070485A8 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES
08/14/2014US20140228562 Treatment of sleep disorders
08/14/2014US20140228370 Substituted imidazopyridazines
08/14/2014US20140228368 Pyrimidine pde10 inhibitors
08/14/2014US20140228367 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228357 Novel compounds as hif-1alphainhibitors and manufacturing process thereof
08/14/2014US20140228353 Compounds and methods of treating diabetes
08/14/2014US20140228350 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
08/14/2014US20140228349 5,7-substituted-imidazo[1,2-c]pyrimidines
08/14/2014US20140228320 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
08/14/2014US20140228319 Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
08/14/2014US20140227321 Anti-viral compounds
08/13/2014EP2765132A1 Dye compounds, and their use in dye-sensitized solar cells
08/13/2014EP2763995A1 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
08/13/2014EP2763994A2 Novel quinoxaline inhibitors of pi3k
08/13/2014EP2763993A1 Heterocyclylpyri(mi)dinylpyrazole
08/13/2014EP2763992A1 NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
08/13/2014EP2763991A1 Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine
08/13/2014EP2763990A1 Pyrrolopyrazine kinase inhibitors
08/13/2014EP2763987A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals
08/13/2014EP2763978A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/13/2014CN103987715A 含氮芳香族化合物、有机半导体材料及有机电子器件 Nitrogen-containing aromatic compound, an organic semiconductor material and an organic electronic device
08/13/2014CN103987714A 金属卟啉配位化合物、其制造方法及由其构成的二氧化碳固定化催化剂、以及环状碳酸酯的制造方法 Metal porphyrin complex compound, its manufacturing method and constituted by the carbon dioxide fixation catalyst, and a method for producing a cyclic carbonate
08/13/2014CN103987713A 5,7-取代的咪唑并[1,2-c]嘧啶 5,7-substituted-imidazo [1,2-c] pyrimidine
08/13/2014CN103987711A 作为用于治疗癌症和免疫性和自身免疫性疾病的凋亡诱导剂的8-氨基甲酰基-2-(2,3-二取代吡啶-6-基)-1,2,3,4-四氢异喹啉衍生物 As 8-Carbamoyl for treating cancer and autoimmune diseases, and immune inducing agent apoptosis-2- (2,3-di-substituted pyridin-6-yl) -1,2,3,4- Hydrogen isoquinoline derivatives
08/13/2014CN103987710A 新的*嗪衍生物及它们在治疗疾病中的应用 * New piperazine derivatives and their use in the treatment of diseases
08/13/2014CN103987707A 吡唑-4-基-杂环基-甲酰胺化合物以及使用方法 Pyrazol-4-yl - heterocyclyl - carboxamide compound, and use of
08/13/2014CN103987699A 作为pi3k调节剂的喹唑啉衍生物 As quinazoline derivatives pi3k moderator
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103987697A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia
08/13/2014CN103987407A 吡咯并苯并二氮杂卓及其偶联物 Pyrrolo benzodiazepines and their conjugates
08/13/2014CN103980282A 一种合成3-氧代吡咯[2,3-b]吲哚类化合物的方法 A method for the synthesis of 3-oxo-pyrrolo [2,3-b] indole compounds
08/13/2014CN103980281A 一种咪唑吡嗪化合物及其制备方法 An imidazole compound and preparation method pyrazine
08/13/2014CN103980280A 一种酸性条件下合成喹唑啉酮并吲唑衍生物的方法 Quinazolinone synthesized under acidic conditions and a method of indole derivatives of
08/13/2014CN103980279A 一种甲氨蝶呤化合物及注射用甲氨蝶呤 One kind of compound methotrexate and methotrexate injection
08/13/2014CN103980278A 右佐匹克隆微晶及其制备方法 Eszopiclone microcrystalline its preparation method
08/13/2014CN102657693B 蛋白质酪氨酸磷酸酶shp-1抑制剂及其制备 Protein tyrosine phosphatase shp-1 inhibitors and their preparation
08/13/2014CN102241679B 合成4H-咪唑并[1,5-a][1,4]苯二氮*特别是咪达唑仑和其盐的方法 Synthesized 4H- imidazo [1,5-a] [1,4] benzodiazepine * especially midazolam and salts thereof
08/13/2014CN102050722B 4-联苯基取代的吡唑烷-3,5-二酮衍生物 4-biphenyl substituted pyrazole-3,5-dione derivative
08/13/2014CN102015636B 作为组胺h3受体拮抗剂的氮杂环丁烷类和环丁烷类化合物 Azetidine as histamine h3 class and cyclobutane receptor antagonist compounds
08/13/2014CN101977915B 大环丝氨酸蛋白酶抑制剂 Macrocyclic serine protease inhibitor
08/12/2014US8802853 Arylalkenyl and arylalkynyl substituted imidazoquinolines
08/12/2014US8802850 Cyclopropyl modulators of P2Y12 receptor
08/12/2014US8802697 Inhibitors of the fibroblast growth factor receptor
08/12/2014US8802690 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/12/2014US8802667 Benzodiazepine derivatives
08/12/2014CA2805543A1 Porphyrin compounds and their use as mri contrast agents
08/12/2014CA2707648C Isoxazolo-pyridine derivatives
08/12/2014CA2585172C Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/12/2014CA2520225C Benzenesulfonamide derivatives
08/07/2014WO2014120800A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120789A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120786A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120784A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120783A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120658A1 Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
08/07/2014WO2014118186A1 Amino-substituted isothiazoles
08/07/2014WO2014118135A1 Amidoimidazopyridazines as mknk-1 kinase inhibitors
08/07/2014WO2014117920A1 Spiro-quinazolinone derivatives useful for the treatment of neurological diseases and conditions
08/07/2014WO2011123751A3 Heterocyclic compounds and their use as pi3k inhibitors
08/07/2014US20140221420 Ccr5 antagonists for treating hiv
08/07/2014US20140221417 Therapeutic compounds
08/07/2014US20140221405 Platelet adp receptor inhibitors
08/07/2014US20140221398 Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
08/07/2014US20140221379 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
08/07/2014US20140221365 Alkylated piperazine compounds
08/07/2014US20140221357 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/07/2014US20140221344 Bicyclic Pyridazine Compounds as PIM Inhibitors
08/07/2014US20140221340 Chemokine receptor activity regulator
08/07/2014US20140221338 Novel macrocycles as factor xia inhibitors
08/07/2014US20140221335 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/07/2014US20140221333 Btk inhibitors
08/07/2014US20140221332 Metabotrophic glutamate receptor 5 modulators and methods of use thereof
08/07/2014US20140221322 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
08/07/2014US20140221315 Pyrimido-pyridazinone compounds and methods of use thereof
08/07/2014US20140221311 Flap modulators
08/07/2014US20140221310 Flap modulators
08/07/2014US20140219915 Cryptate compounds
08/07/2014DE112012004870T5 Organisches Elektrolumineszenzelement, Material für ein organisches Elektrolumineszenzelement, lichtemittierende Vorrichtung, Anzeigevorrichtung und Beleuchtungsvorrichtung die jeweils das Element verwenden, und in dem Element verwendete Verbindung Organic electroluminescent material for an organic electroluminescence light emitting device, display device, and lighting device each using the element, and used in the connection element
08/06/2014EP2762480A1 Oxazolidinone antibiotics containing fused ring
08/06/2014EP2762478A1 Aromatic amine derivative and organic electroluminescence element using same
08/06/2014EP2762475A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use
08/06/2014EP2760867A1 Macrocyclic flt3 kinase inhibitors
08/06/2014EP2760866A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists
08/06/2014EP2760863A1 Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
08/06/2014EP2760857A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
08/06/2014EP2760831A1 Viral replication inhibitors
08/06/2014EP2760453A1 Macrocyclic lrrk2 kinase inhibitors
08/06/2014CN103974956A 作为hdac6抑制剂和用作抗肿瘤剂的杂环酰胺化合物 As hdac6 inhibitor and as an anti-tumor agent heterocyclic amide compound
08/06/2014CN103974955A 嘧啶并-哒嗪酮化合物及其用途 Pyrimido - pyridazinone compound and use thereof
08/06/2014CN103974938A 作为因子xia抑制剂的经取代的四氢异喹啉化合物 As inhibitors of factor xia substituted tetrahydroisoquinoline compound
08/06/2014CN103965205A 一种超临界提纯生产叶绿素铜钠的方法 Supercritical purification method for the production of sodium copper chlorophyll
08/06/2014CN103965204A 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 Indazolo [5,4-a] pyrrolo [3,4-c] carbazole compounds of the new forms of
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 573